Avantor Sciences

Avantor, a $6 billion leader in lab chemicals for pharma and biotech, acquired VWR, a global distributor of research lab products, in late 2017. With extensive experience in biotech and biopharma—working closely with our client—we helped create a new brand that would transform the merged company into an integrated discovery-to-delivery provider. This project involved tight deadlines, several ever-evolving deliverables, and many stakeholders from two strong legacy brands. All while implementing the branding changes in a way that would not disrupt the intricate workings of their day-to-day business.

 

Guided by a core brand idea—Setting Science in Motion To Create a Better World—the new brand was successfully launched, and a new organization emerged.

​

In May 2019, Avantor Sciences IPO raised $2.9 billion,
the second biggest IPO of the year.